Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Notes Payables (2022 - 2024)

Adaptin Bio's (APTN) quarterly Notes Payables came in at $544957.0 in Q4 2024, up 570.97% year-over-year from $81219.0 in Q1 2024, and up 295.57% quarter-over-quarter from $137764.0 in Q3 2024.

Analysis

Adaptin Bio (APTN) Notes Payables (2022 - 2024) Analysis & Trends

Adaptin Bio has disclosed Notes Payables across 3 years of filings, most recently posting $544957.0 for Q4 2024.

  • In Q4 2024, Notes Payables rose 570.97% year-over-year to $544957.0; the TTM figure through Dec 2024 stood at $544957.0 (up 570.97% YoY), while the FY2024 annual figure was $544957.0, up 570.97% from the prior year.
  • Notes Payables came in at $544957.0 for Q4 2024 at Adaptin Bio, up from $137764.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $544957.0 in Q4 2024 to a low of $304.0 in Q4 2022.
  • Average Notes Payables over 3 years is $140129.6, with a median of $81219.0 recorded in 2023.
  • Year-over-year, Notes Payables jumped 26616.78% in 2023 and soared 502.33% in 2024.
  • Over 3 years, Notes Payables stood at $304.0 in 2022, then jumped by 26616.78% to $81219.0 in 2023, then soared by 570.97% to $544957.0 in 2024.
  • Per Business Quant data, the three most recent Notes Payables figures were $544957.0 in Q4 2024, $137764.0 in Q3 2024, and $112572.0 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Adaptin Bio 56.76 Mn 56.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 544,957.00
Sep 30, 2024 137,764.00
Jun 30, 2024 112,572.00
Mar 31, 2024 81,219.00
Dec 31, 2023 81,219.00
Sep 30, 2023 22,872.00
Dec 31, 2022 304.00